VANI - Latest News

Vivani Medical, Inc. (VANI), operates in Healthcare / Medical - Devices, trades on NASDAQ.

Market capitalization stands near $68.5M. Beta to the broader market is 3.37.

The article list below shows the most recent VANI headlines from major financial news vendors. For options traders, the most actionable items are earnings releases, analyst rating changes, M&A activity, and regulatory filings - each can drive a meaningful repricing of implied volatility and shift dealer hedging flow. Pair the news context with the implied-volatility skew and gamma exposure views to see whether the options market has already priced in the headline.

Recent VANI Headlines

Vivani Medical Reports First Quarter 2026 Financial Results and Provides Business Update

globenewswire.com - May 13, 2026

Initiation of SLIM-1™ clinical trial, a Phase 1 study of NPM-139, a semaglutide implant under development for chronic weight management, on track for

Insider Buying: Vivani Medical (NASDAQ:VANI) Director Purchases $1,999,999.26 in Stock

defenseworld.net - Apr 19, 2026

Vivani Medical, Inc. (NASDAQ: VANI - Get Free Report) Director Gregg Williams purchased 1,587,301 shares of the firm's stock in a transaction that oc

Vivani Medical, Inc. (NASDAQ:VANI) Short Interest Up 65.0% in March

defenseworld.net - Apr 15, 2026

Vivani Medical, Inc. (NASDAQ: VANI - Get Free Report) was the recipient of a significant increase in short interest in the month of March.

Critical Survey: Verrica Pharmaceuticals (NASDAQ:VRCA) vs. Vivani Medical (NASDAQ:VANI)

defenseworld.net - Apr 5, 2026

Vivani Medical (NASDAQ: VANI - Get Free Report) and Verrica Pharmaceuticals (NASDAQ: VRCA - Get Free Report) are both small-cap medical companies, but

Vivani Medical (VANI) Upgraded to Buy: What Does It Mean for the Stock?

zacks.com - Apr 3, 2026

Vivani Medical (VANI) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might driv

How News Affects VANI Options Pricing

Headlines and scheduled events drive implied volatility in two distinct ways. Pre-event, IV typically inflates as uncertainty about the outcome rises; this is the implied-volatility expansion that creates the long-vol setup. Post-event, IV typically contracts sharply as uncertainty resolves; this is IV crush, which makes premium-selling structures profitable when they survive the underlying move. The size of the crush depends on how stretched pre-event IV is relative to the realized move. Track VANI's implied vs realized volatility over the news cycle to size pre-event vs post-event positioning. For ticker-level dealer positioning context, the gamma exposure view shows whether dealers are positioned to amplify or dampen post-news moves.

Frequently asked VANI news questions

What is the latest VANI news headline?

The most recent VANI headline (May 13, 2026) is "Vivani Medical Reports First Quarter 2026 Financial Results and Provides Business Update". The five most recent stories with summaries and publication times are listed above, sourced from major financial news vendors.

How fresh is the VANI news on this page?

News rows refresh roughly every 30 minutes during the trading day. The five most recent headlines are listed in publication-time order. Press releases from the company itself typically appear within minutes of the wire release; third-party reporting may lag by 30-60 minutes depending on the source.

What VANI news moves options pricing?

Three categories move single-name IV most aggressively: scheduled earnings releases (priced into pre-event IV, crushed post-event), unscheduled M&A or strategic announcements (rapid IV expansion, slower decay), and regulatory or legal events (drug-trial readouts, antitrust filings, FDA approvals). Routine news flow (analyst commentary, sector rotation) typically does not move IV meaningfully unless it triggers a cluster of rating changes.

How can I track unusual VANI options activity related to news?

Unusual options activity often precedes news by hours to days; the canonical signals are volume substantially above the trailing average concentrated in a small number of strikes, atypical put/call skew, and aggressive execution (at-the-ask sweeps or block prints). Cross-reference the per-ticker gamma-exposure and volume-history pages with the news flow above to triangulate informed vs uninformed flow.